Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Pediatric Hip Reconstruction
NCT04811313Recruiting
- Sponsor
- Assiut University
- Start
- Apr 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tranexamic acid in Intraoperative blood loss (EBL) (4 arms), sponsored by Assiut University. Primary endpoint: Amount of intraoperative blood loss at 24 hours. Started Apr 2025; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Intraoperative blood loss (EBL)
Beyond the preview
Go deeper on NCT04811313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04811313.